Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 Years
Sharon Nachman(State University of New York), H. N. Ndiweni, Xin Xu(Merck & Co., Inc., Rahway, NJ, USA (United States)), John Swetnam, Brenda Homony(Merck & Co., Inc., Rahway, NJ, USA (United States)), Harry Moultrie(National Institute of Allergy and Infectious Diseases), L. J. Utech, Stephen A. Spector(University of California San Diego), Bobbie Graham(Frontier Science & Technology Research Foundation, Inc.), Breno Santos(Hospital Nossa Senhora da Conceição), Marc Foca(Albert Einstein College of Medicine), Hedy Teppler(Unknown), Raziya Bobat(Jacobi Medical Center), Naomi J. Patel(Evidence (Italy)), Jaime G. Deville(University of California, Los Angeles), Mónica Acevedo(National Institute of Allergy and Infectious Diseases), Lisa M. Frenkel(Center for Infectious Disease Research), Marlene Burey(National Institute of Allergy and Infectious Diseases), S. Dittmer(National Institute of Allergy and Infectious Diseases), M. Rigaud(National Institute of Allergy and Infectious Diseases), Mark E. Rosenberg(University of Minnesota Medical Center), S. Akleh(National Institute of Allergy and Infectious Diseases), Edward Handelsman(National Institutes of Health), Karin Nielsen‐Saines(University of California, Los Angeles), Jesica Pagano‐Therrien, Margaret Ann Sanders(National Institute of Allergy and Infectious Diseases), Naiyu Zheng(Harvard University), Andrea Jurgrau, G. Kindra(Merck & Co., Inc., Rahway, NJ, USA (United States)), Airton Mota Moreira(National Institute of Allergy and Infectious Diseases), Joan Wilson, Evelina Cardoso(Jacobi Medical Center), L. Fabregas(National Institute of Allergy and Infectious Diseases), Katherine Luzuriaga(University of Massachusetts Chan Medical School), Aditya Kaul, Ruth Williams(Jacobi Medical Center), Abigail Higgins, D. Picard(Jacobi Medical Center), R. Mngqibisa(Jacobi Medical Center), Ashok Gaur, T. Fenton(Harvard University), Jacobo Abadi, Michael Donnelly(National Institute of Allergy and Infectious Diseases), Larissa Wenning(Merck & Co., Inc., Rahway, NJ, USA (United States)), Edward P. Acosta(University of Alabama at Birmingham), C. Worrell(National Institutes of Health), Andrew Wiznia(Jacobi Medical Center), Michele Carter(Seattle Children's Hospital), C. Alvero(Harvard University), Jennifer Jensen(Texas State University)
Cited by 60
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|2004|921
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828